Pablo Angiono currently serves as Country Manager at Eurofarma, managing pharmaceutical operations including innovative and OTC products as well as manufacturing facilities since December 2022. Prior experience includes roles at AstraZeneca as Pharma Business Unit Director for the South Cone and various positions such as Commercial & Established Brands Director for Argentina and Uruguay, focusing on multiple therapeutic areas. At GSK, Pablo held several leadership positions in commercial excellence, global market access, and project management. Career beginnings include roles at AC Nielsen, KPMG, and Arthur Andersen, starting as a Semi-Senior Auditor and Audit Analyst. Pablo holds an MBA from Universidad del CEMA and degrees in Business Administration and Accounting from Universidad Nacional de La Matanza.